Complement Regulates Nutrient Influx and Metabolic Reprogramming during Th1 Cell Responses

Immunity

Volumn 42, Issue 6, 2015, Pages 1033-1047

  Kolev, Martin ^a   Dimeloe, Sarah ^b   Le Friec, Gaelle ^a   Navarini, Alexander ^c   Arbore, Giuseppina ^a   Povoleri, Giovanni A ^a   Fischer, Marco ^b   Belle, Réka ^b   Loeliger, Jordan ^b   Develioglu, Leyla ^b   Bantug, Glenn R ^b   Watson, Julie ^a   Couzi, Lionel ^d   Afzali, Behdad ^a,e   Lavender, Paul ^a   Hess, Christoph ^b   Kemper, Claudia ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BASEL   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d HÔPITAL PELLEGRIN   (France)

^e NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID TRANSPORTER; AMINO ACID TRANSPORTER LAT1; COMPLEMENT; COMPLEMENT RECEPTOR; COMPLEMENT RECEPTOR CD46; DNA; GAMMA INTERFERON; GLUCOSE TRANSPORTER 1; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 4; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MEMBRANE COFACTOR PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; UNCLASSIFIED DRUG; HBXIP PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; MECHANISTIC TARGET OF RAPAMYCIN COMPLEX 1; MONOMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; MULTIPROTEIN COMPLEX; NEUROPEPTIDE; RAG-1 PROTEIN; RHEB PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SMALL INTERFERING RNA; TARGET OF RAPAMYCIN KINASE;

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; CELL METABOLISM; CELL TRANSPORT; CELLULAR IMMUNITY; COMPLEMENT SYSTEM; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME PHOSPHORYLATION; EXOME; GENE SEQUENCE; GENE SILENCING; GLYCOLYSIS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOREGULATION; JURKAT CELL LINE; MITOCHONDRIAL RESPIRATION; MOUSE; NONHUMAN; NUCLEAR REPROGRAMMING; NUCLEOTIDE SEQUENCE; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN EXPRESSION; STEADY STATE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; UPREGULATION; CELL CULTURE; CELL DIFFERENTIATION; GENETICS; HEMOLYTIC UREMIC SYNDROME; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANTIGENS, CD46; CELL DIFFERENTIATION; CELLS, CULTURED; CELLULAR REPROGRAMMING; COMPLEMENT SYSTEM PROTEINS; GLUCOSE TRANSPORTER TYPE 1; GLYCOLYSIS; HEMOLYTIC-UREMIC SYNDROME; HOMEODOMAIN PROTEINS; HUMANS; IMMUNITY, CELLULAR; INTERFERON-GAMMA; LARGE NEUTRAL AMINO ACID-TRANSPORTER 1; MONOMERIC GTP-BINDING PROTEINS; MULTIPROTEIN COMPLEXES; NEUROPEPTIDES; OXIDATIVE PHOSPHORYLATION; RNA, SMALL INTERFERING; TH1 CELLS; TOR SERINE-THREONINE KINASES; UP-REGULATION;

EID: 84937604783     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2015.05.024     Document Type: Article

References (57)

1. Astier A., Trescol-Biémont M.C., Azocar O., Lamouille B., Rabourdin-Combe C. Cutting edge: CD46, a new costimulatory molecule for Tcells, that induces p120CBL and LAT phosphorylation. J.Immunol. 2000, 164:6091-6095.
2. Astier A.L., Meiffren G., Freeman S., Hafler D.A. Alterations in CD46-mediated Tr1 regulatory Tcells in patients with multiple sclerosis. J.Clin. Invest. 2006, 116:3252-3257.
3. Bachar E., Ariav Y., Ketzinel-Gilad M., Cerasi E., Kaiser N., Leibowitz G. Glucose amplifies fatty acid-induced endoplasmic reticulum stress in pancreatic beta-cells via activation of mTORC1. PLoS ONE 2009, 4:e4954.
4. Bar-Peled L., Sabatini D.M. Regulation of mTORC1 by amino acids. Trends Cell Biol. 2014, 24:400-406.
5. Bar-Peled L., Schweitzer L.D., Zoncu R., Sabatini D.M. Ragulator is a GEF for the rag GTPases that signal amino acid levels to mTORC1. Cell 2012, 150:1196-1208.
6. Bhaskar P.T., Nogueira V., Patra K.C., Jeon S.M., Park Y., Robey R.B., Hay N. mTORC1 hyperactivity inhibits serum deprivation-induced apoptosis via increased hexokinase II and GLUT1 expression, sustained Mcl-1 expression, and glycogen synthase kinase 3beta inhibition. Mol. Cell. Biol. 2009, 29:5136-5147.
7. Cardone J., Le Friec G., Vantourout P., Roberts A., Fuchs A., Jackson I., Suddason T., Lord G., Atkinson J.P., Cope A., et al. Complement regulator CD46 temporally regulates cytokine production by conventional and unconventional Tcells. Nat. Immunol. 2010, 11:862-871.
8. Cattaneo R. Four viruses, two bacteria, and one receptor: membrane cofactor protein (CD46) as pathogens' magnet. J.Virol. 2004, 78:4385-4388.
9. Chang C.H., Curtis J.D., Maggi L.B., Faubert B., Villarino A.V., O'Sullivan D., Huang S.C., van der Windt G.J., Blagih J., Qiu J., et al. Posttranscriptional control of Tcell effector function by aerobic glycolysis. Cell 2013, 153:1239-1251.
10. Ciofani M., Zúñiga-Pflücker J.C. Notch promotes survival of pre-T cells at the beta-selection checkpoint by regulating cellular metabolism. Nat. Immunol. 2005, 6:881-888.
11. Cope A., Le Friec G., Cardone J., Kemper C. The Th1 life cycle: molecular control of IFN-γ to IL-10 switching. Trends Immunol. 2011, 32:278-286.
12. Couzi L., Contin-Bordes C., Marliot F., Sarrat A., Grimal P., Moreau J.F., Merville P., Fremeaux-Bacchi V. Inherited deficiency of membrane cofactor protein expression and varying manifestations of recurrent atypical hemolytic uremic syndrome in a sibling pair. Am. J. Kidney Dis. 2008, 52:e5-e9.
13. Cunningham J.T., Rodgers J.T., Arlow D.H., Vazquez F., Mootha V.K., Puigserver P. mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex. Nature 2007, 450:736-740.
14. Delgoffe G.M., Kole T.P., Zheng Y., Zarek P.E., Matthews K.L., Xiao B., Worley P.F., Kozma S.C., Powell J.D. The mTOR kinase differentially regulates effector and regulatory Tcell lineage commitment. Immunity 2009, 30:832-844.
15. Düvel K., Yecies J.L., Menon S., Raman P., Lipovsky A.I., Souza A.L., Triantafellow E., Ma Q., Gorski R., Cleaver S., et al. Activation of ametabolic gene regulatory network downstream of mTOR complex 1. Mol. Cell 2010, 39:171-183.
16. Frauwirth K.A., Riley J.L., Harris M.H., Parry R.V., Rathmell J.C., Plas D.R., Elstrom R.L., June C.H., Thompson C.B. The CD28 signaling pathway regulates glucose metabolism. Immunity 2002, 16:769-777.
17. Fremeaux-Bacchi V., Moulton E.A., Kavanagh D., Dragon-Durey M.A., Blouin J., Caudy A., Arzouk N., Cleper R., Francois M., Guest G., et al. Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome. J.Am. Soc. Nephrol. 2006, 17:2017-2025.
18. Gerriets V.A., Rathmell J.C. Metabolic pathways in Tcell fate and function. Trends Immunol. 2012, 33:168-173.
19. Gerriets V.A., Kishton R.J., Nichols A.G., Macintyre A.N., Inoue M., Ilkayeva O., Winter P.S., Liu X., Priyadharshini B., Slawinska M.E., et al. Metabolic programming and PDHK1 control CD4+ Tcell subsets and inflammation. J.Clin. Invest. 2015, 125:194-207.
20. Groenewoud M.J., Zwartkruis F.J. Rheb and Rags come together at the lysosome to activate mTORC1. Biochem. Soc. Trans. 2013, 41:951-955.
21. Gubser P.M., Bantug G.R., Razik L., Fischer M., Dimeloe S., Hoenger G., Durovic B., Jauch A., Hess C. Rapid effector function of memory CD8+ Tcells requires an immediate-early glycolytic switch. Nat. Immunol. 2013, 14:1064-1072.
22. Hayashi K., Jutabha P., Endou H., Sagara H., Anzai N. LAT1 is a critical transporter of essential amino acids for immune reactions in activated human Tcells. J.Immunol. 2013, 191:4080-4085.
23. Jacobs S.R., Herman C.E., Maciver N.J., Wofford J.A., Wieman H.L., Hammen J.J., Rathmell J.C. Glucose uptake is limiting in Tcell activation and requires CD28-mediated Akt-dependent and independent pathways. J.Immunol. 2008, 180:4476-4486.
24. Jones R.G., Thompson C.B. Revving the engine: signal transduction fuels Tcell activation. Immunity 2007, 27:173-178.
25. Kemper C., Leung M., Stephensen C.B., Pinkert C.A., Liszewski M.K., Cattaneo R., Atkinson J.P. Membrane cofactor protein (MCP; CD46) expression in transgenic mice. Clin. Exp. Immunol. 2001, 124:180-189.
26. Kemper C., Chan A.C., Green J.M., Brett K.A., Murphy K.M., Atkinson J.P. Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 2003, 421:388-392.
27. Kolev M., Le Friec G., Kemper C. Complement-tapping into new sites and effector systems. Nat. Rev. Immunol. 2014, 14:811-820.
28. Landor S.K., Mutvei A.P., Mamaeva V., Jin S., Busk M., Borra R., Grönroos T.J., Kronqvist P., Lendahl U., Sahlgren C.M. Hypo- and hyperactivated Notch signaling induce a glycolytic switch through distinct mechanisms. Proc. Natl. Acad. Sci. USA 2011, 108:18814-18819.
29. Le Friec G., Kemper C. Complement: coming full circle. Arch. Immunol. Ther. Exp. (Warsz.) 2009, 57:393-407.
30. Le Friec G., Sheppard D., Whiteman P., Karsten C.M., Shamoun S.A., Laing A., Bugeon L., Dallman M.J., Melchionna T., Chillakuri C., et al. The CD46-Jagged1 interaction is critical for human TH1 immunity. Nat. Immunol. 2012, 13:1213-1221.
31. Liszewski M.K., Atkinson J.P. Membrane cofactor protein (MCP; CD46). Isoforms differ in protection against the classical pathway of complement. J.Immunol. 1996, 156:4415-4421.
32. Liszewski M.K., Post T.W., Atkinson J.P. Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster. Annu. Rev. Immunol. 1991, 9:431-455.
33. Liszewski M.K., Kolev M., Le Friec G., Leung M., Bertram P.G., Fara A.F., Subias M., Pickering M.C., Drouet C., Meri S., et al. Intracellular complement activation sustains Tcell homeostasis and mediates effector differentiation. Immunity 2013, 39:1143-1157.
34. Long X., Ortiz-Vega S., Lin Y., Avruch J. Rheb binding to mammalian target of rapamycin (mTOR) is regulated by amino acid sufficiency. J.Biol. Chem. 2005, 280:23433-23436.
35. Macintyre A.N., Gerriets V.A., Nichols A.G., Michalek R.D., Rudolph M.C., Deoliveira D., Anderson S.M., Abel E.D., Chen B.J., Hale L.P., Rathmell J.C. The glucose transporter Glut1 is selectively essential for CD4 Tcell activation and effector function. Cell Metab. 2014, 20:61-72.
36. MacIver N.J., Michalek R.D., Rathmell J.C. Metabolic regulation of T lymphocytes. Annu. Rev. Immunol. 2013, 31:259-283.
37. Maekawa Y., Ishifune C., Tsukumo S., Hozumi K., Yagita H., Yasutomo K. Notch controls the survival of memory CD4+ Tcells by regulating glucose uptake. Nat. Med. 2015, 21:55-61.
38. Marinari B., Costanzo A., Marzano V., Piccolella E., Tuosto L. CD28 delivers a unique signal leading to the selective recruitment of RelA and p52 NF-kappaB subunits on IL-8 and Bcl-xL gene promoters. Proc. Natl. Acad. Sci. USA 2004, 101:6098-6103.
39. Matheny R.W., Adamo M.L. Effects of PI3K catalytic subunit and Akt isoform deficiency on mTOR and p70S6K activation in myoblasts. Biochem. Biophys. Res. Commun. 2009, 390:252-257.
40. Michalek R.D., Gerriets V.A., Jacobs S.R., Macintyre A.N., MacIver N.J., Mason E.F., Sullivan S.A., Nichols A.G., Rathmell J.C. Cuttingedge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ Tcell subsets. J.Immunol. 2011, 186:3299-3303.
41. Ni Choileain S., Weyand N.J., Neumann C., Thomas J., So M., Astier A.L. The dynamic processing of CD46 intracellular domains provides a molecular rheostat for Tcell activation. PLoS ONE 2011, 6:e16287.
42. Pearce E.L., Poffenberger M.C., Chang C.H., Jones R.G. Fueling immunity: insights into metabolism and lymphocyte function. Science 2013, 342:1242454.
43. Pollizzi K.N., Powell J.D. Integrating canonical and metabolic signalling programmes in the regulation of Tcell responses. Nat. Rev. Immunol. 2014, 14:435-446.
44. Rathmell J.C. Metabolism and autophagy in the immune system: immunometabolism comes of age. Immunol. Rev. 2012, 249:5-13.
45. Roos S., Kanai Y., Prasad P.D., Powell T.L., Jansson T. Regulation of placental amino acid transporter activity by mammalian target of rapamycin. Am. J. Physiol. Cell Physiol. 2009, 296:C142-C150.
46. Sancak Y., Bar-Peled L., Zoncu R., Markhard A.L., Nada S., Sabatini D.M. Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell 2010, 141:290-303.
47. Sena L.A., Li S., Jairaman A., Prakriya M., Ezponda T., Hildeman D.A., Wang C.R., Schumacker P.T., Licht J.D., Perlman H., et al. Mitochondria are required for antigen-specific Tcell activation through reactive oxygen species signaling. Immunity 2013, 38:225-236.
48. Shi L.Z., Wang R., Huang G., Vogel P., Neale G., Green D.R., Chi H. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J.Exp. Med. 2011, 208:1367-1376.
49. Sinclair L.V., Rolf J., Emslie E., Shi Y.B., Taylor P.M., Cantrell D.A. Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for Tcell differentiation. Nat. Immunol. 2013, 14:500-508.
50. Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., Paulovich A., Pomeroy S.L., Golub T.R., Lander E.S., Mesirov J.P. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 2005, 102:15545-15550.
51. Thai M., Graham N.A., Braas D., Nehil M., Komisopoulou E., Kurdistani S.K., McCormick F., Graeber T.G., Christofk H.R. Adenovirus E4ORF1-induced MYC activation promotes host cell anabolic glucose metabolism and virus replication. Cell Metab. 2014, 19:694-701.
52. van der Windt G.J., Everts B., Chang C.H., Curtis J.D., Freitas T.C., Amiel E., Pearce E.J., Pearce E.L. Mitochondrial respiratory capacity isa critical regulator of CD8+ Tcell memory development. Immunity 2012, 36:68-78.
53. van der Windt G.J., O'Sullivan D., Everts B., Huang S.C., Buck M.D., Curtis J.D., Chang C.H., Smith A.M., Ai T., Faubert B., et al. CD8 memory Tcells have a bioenergetic advantage that underlies their rapid recall ability. Proc. Natl. Acad. Sci. USA 2013, 110:14336-14341.
54. Viola A., Lanzavecchia A. T cell activation determined by Tcell receptor number and tunable thresholds. Science 1996, 273:104-106.
55. Wang R., Dillon C.P., Shi L.Z., Milasta S., Carter R., Finkelstein D., McCormick L.L., Fitzgerald P., Chi H., Munger J., Green D.R. The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity 2011, 35:871-882.
56. Wofford J.A., Wieman H.L., Jacobs S.R., Zhao Y., Rathmell J.C. IL-7 promotes Glut1 trafficking and glucose uptake via STAT5-mediated activation of Akt to support T-cell survival. Blood 2008, 111:2101-2111.
57. Zheng Y., Collins S.L., Lutz M.A., Allen A.N., Kole T.P., Zarek P.E., Powell J.D. A role for mammalian target of rapamycin in regulating Tcell activation versus anergy. J.Immunol. 2007, 178:2163-2170.